(5-methylimidazo[1,2-a]pyridin-3-yl)methanol, 95.0%, 1g

N*1*-(6-Morpholin-4-yl-3-nitro-4-trifluoromethyl-pyridin-2-yl)-propane-1,3-diamine, 95.0%, 1g

3-METHOXY-4-(TRIFLUOROMETHYL)PHENYLACETIC ACID, 95%, 250mg

1-Butyl-1-phenylhydrazine>98.0%(T)5g

4,4,5,5-TETRAMETHYL-2-(4-((4-(TRIFLUOROMETHYL)BENZYL)OXY)PHENYL)-1,3,2-DIOXABOROLANE, 95%, 1g

2,6-Diaminopyridine>98.0%(GC)(T)25g

3-(Dimethylamino)benzoic acid, 97.0%, 1kg

SRC KINASE INHIBITOR I, 95%, 25mg

1-(3-Bromophenyl)-2,2-dimethylpropan-1-amine, 95%, 100mg

(dimethylamino)(3-methylphenyl)acetic acid hydrochloride, 95.0%, 25g

Butyl benzenesulfonate, 95%, 5g

N,N-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 97%, 5g

3,5-Dichlorobenzimidamide hydrochloride, 95.0%, 1g